Moreover, the overexpression of MRP1 has also been implicated in the development of multidrug resistance in several cancers like ovarian, lung, breast, pancreatic, kidney carcinomas, and in malignant melanoma (Barrand et al., 1993; Larkin et al., 2004; Li et al., 2009; O’Driscoll et al., 2007; Tong et al., 2019; Walsh et al., 2010; Walsh et al., 2009). The gene discussed is ABCC1; the disease is cancer.